NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Qure Biotechnology (Shanghai) Co., Ltd.

Qure Biotechnology (Shanghai) Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://qurebio.com

Last Round

Series C

Extension

Jun 5, 2025

Total Funding Raised

$46.9M

Company Overview

Qure Biotechnology (Shanghai) Co., Ltd. is a biopharmaceutical company that develops bispecific and multispecific antibody and protein therapeutics for the treatment of cancer, autoimmune diseases, and inflammatory disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

bispecific antibodymultispecific antibodyantibody engineeringbiologicsprotein therapeuticsT-cell engagerNK-cell engagerdrug discoverybiotech licensingoncology therapeuticsclinical-stage biotechbiopharmanext-gen biologicsdrug pipelineR&D collaboration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qure Biotechnology (Shanghai) Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Qure Biotechnology (Shanghai) Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Qure Biotechnology (Shanghai) Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionJun 5, 2025
Series BDec 23, 2021
VC RoundJul 29, 2020
Series A ExtensionApr 10, 2020
Series AAug 12, 2019
Angel
May 1, 2017

Qure Biotechnology (Shanghai) Co., Ltd. Investors

Notable investors and investment history

Qure Biotechnology (Shanghai) Co., Ltd. investors
InvestorRounds
Longmen CapitalSeries B
Oriza HoldingsSeries B
Shanghai Zhangjiang Torch Venture CapitalSeries B
Viva BioInnovatorAngel
Guoshun InvestmentSeries B
BOCOM International Holdings Company LimitedSeries B
Efung CapitalSeries C Extension

Qure Biotechnology (Shanghai) Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qure Biotechnology (Shanghai) Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qure Biotechnology (Shanghai) Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range1
Year Founded2017
Last FundingJun 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.